Analysis into the Mexican Diabetes Therapy Market Which Has over 10 Million Diabetic Sufferers

DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/60722f/mexican_diabetes_t) has announced the addition of Frost & Sullivan's new report "Mexican Diabetes Therapy Market" to their offering.

Currently in Mexico there are more than 10 million diabetics, from which only 20% is under correct control. Population growth and aging are some of the factors that keep increasing the potential for this market. Consequently increasingly more brands and products have been introduced into this market, splitting the diabetes therapy business in three segments: insulin, anti diabetes drugs and self monitoring accessories. Therefore, pharmaceutical companies face a tough competitive environment, in order to gain public and private healthcare sectors' share.

Key Topics Covered:
MEXICAN MARKET INTRODUCTION AND EXECUTIVE SUMMARY
- Market Introduction and Executive Summary
- - Executive Summary
- - Overview of the Mexican Healthcare System
- - The Diabetes Business within the Mexican Pharmaceutical Market
- Mexico
- Diabetes Therapy Market
- - Market Measurements
- - Industry Challenges
- - Market Drivers
- - Market Restraints
- Market Forecast by Segment
- - Insulin
- - Antidiabetes Drugs
- - Self-monitoring Accessories
- Competitive Analysis and Market Share
- - Insulin
- - Antidiabetes Drugs
- - Self-monitoring Accessories

For more information visit http://www.researchandmarkets.com/research/60722f/mexican_diabetes_t